ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1074

TLR2 Deletion Promotes Arthritis and Joint Destruction Through Reduction of IL-10

Qi Quan Huang1, Renee E. Koessler1, Robert Birkett2, Harris R. Perlman3, Lianping Xing4 and Richard M. Pope5, 1Medicine/Rheumatology, Northwestern University, Chicago, IL, 2Division of Rheumatology, Department od Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Feinberg School of Medicine, Northwestern University, Chicago, IL, 4Pathology & Lab Medicine, University of Rochester, Rochester, NY, 5Rheumatology, Northwestern University Feinberg school of Medicine, Chicago, IL

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Animal models, cytokines, Fc receptors, inflammation and macrophage activation syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Innate Immunity and Rheumatic Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose:

TLR2 signaling pathway has been suggested as a potential therapeutic target in RA.  However, studies with mice deficient in TLR2 (TLR2-/-) and IL-1Ra suggest that TLR2 may suppress arthritis mediated through increased interferon-γ, and reduced TGFβ and T regulatory cell function.  In order to determine the role of TLR2 deletion on the effector phase of arthritis, studies were performed with the K/BxN serum transfer model of RA, mediated by antibodies to glucose-6-phosphate isomerase (GPI) which results in an immune complex-mediated arthritis. 

Methods:

Wild type and homozygous Tlr2tm1Kir mutation (Tlr2-/-) mice on the C57Bl/6 background were injected intraperitoneally with 100 ml anti-GPI serum and evaluated between days 0 to 9 post-induction by ankle swelling and clinical score.  Ankles were harvested and sections analyzed by hematoxylin and eosin, and TRAP activity staining for osteoclasts.  IL-1b, IL-10, RANKL and osteoprotegerin (OPG) in ankle homogenates were quantified by ELISA.  Bone marrow-derived macrophages (BMM) were generated from wild type and Tlr2-/- mice by in vitro differentiation in GM-CSF for 7 days.  BMM activation was induced by incubation with model immune complexes employing mouse IgG coated on plastic plates for 4 hours. Supernatants were assessed for TNFα and IL-10 expression by ELISA.  The macrophage Fc receptor mediated macrophage signaling was assessed by immunoblot analysis employing phospho-antibodies to Akt, p38, and ERK.  Fc receptor expression on cell membranes was determined employing antibodies to CD16/CD32, analyzed by flow cytometry.  Macrophage Fc receptor isoform expression at mRNA level was determined by quantitative real-time RT-PCR.

Results:

The transfer of anti-GPI serum resulted in significantly worse arthritis in TLR2-/- mice compared to wild type controls.  Histological exam demonstrated more inflammation and joint destruction.  Examination of the joints homogenates collected at the peak of inflammation (day7 post-induction) revealed increased IL-1b and decreased IL-10 in TLR2-/- mice.  TLR2 deficiency also resulted in increased osteoclasts, identified by TRAP staining.  There was a trend toward reduction of OPG (p = 0.056) in the ankles of TLR2-/- mice, and a strong negative correlation (p < 0.001) between OPG and joint swelling.  There was no difference in the expression of inhibitory or activating Fc receptors in TLR2-/- mice.  However, activation of TLR2-/- macrophages with immune complexes resulted in significantly reduced IL-10, while there was no difference in TNFa, compared to the controls.  Macrophages from the TLR2-/- demonstrated decreased activation of Akt, but not ERK or p38, following activation with immune complexes. 

Conclusion:

These observations demonstrate that deletion of TLR2 exacerbates serum transfer-induced arthritis.  In the absence of TLR2, there was a reduction of IL-10 in the joints, and this may be due to the reduced activation of Akt by immune complexes.  These observations demonstrate cross-talk between TLR2 and Fc receptor signaling modulates the effector phase of inflammatory arthritis.


Disclosure:

Q. Q. Huang,
None;

R. E. Koessler,
None;

R. Birkett,
None;

H. R. Perlman,
None;

L. Xing,
None;

R. M. Pope,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/tlr2-deletion-promotes-arthritis-and-joint-destruction-through-reduction-of-il-10/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology